INFORM – INdividualized therapy FOr high-Risk childhood Malignancies

Despite modern therapies, the treatment of relapses and high-risk diseases in childhood and adolescence remains a major challenge. The INFORM consortium (“INdividualized therapy FOr high-Risk childhood Malignancies”) brings together leading physicians, genome research scientists and pediatric oncology study groups of the GPOH to develop innovative, personalized therapeutic approaches for affected children.